How much does it cost to buy a box of Etrasimod-Velsipity on the market?

Etrasimod is an innovative small molecule drug developed by Arena Pharmaceuticals and later introduced to the market by Pfizer. It is mainly used to treat moderate to severe active ulcerative colitis (UC). As a selective S1P receptor modulator, the drug can effectively reduce the aggregation of lymphocytes in the intestinal mucosa, thereby alleviating inflammation and tissue damage. Its emergence brings new hope to patients for whom traditional treatments are ineffective.

In terms of clinical application, itridimod is suitable for patients with UC who have insufficient response or poor tolerance to conventional treatments. Because it is an oral drug, its once-daily administration greatly improves compliance and is more convenient than biologics that require intravenous infusion. This drug delivery mode not only facilitates long-term disease management for patients, but also has strong practical significance in the treatment of chronic diseases. Currently, it has been approved by the U.S. Food and Drug Administration (FDA) and is gradually being launched in Europe and other regions.

In terms of price, because itrimod is still under patent and is an original and innovative drug, its price is relatively expensive. According to overseas market information, the price of a single box of the American or European version of Velsipity is roughly between RMB 10,000 and RMB 30,000. The specific price will vary depending on the country, pharmacy channels, and medical insurance reimbursement policies. It is worth noting that the drug has not yet been officially launched in mainland China, so it is not included in the national medical insurance directory. If patients need to use it, they can only rely on overseas purchase of drugs or cross-border medical services, which virtually increases the cost of medication.

There are currently no generic versions of itramod on the market, which means that its price is likely to remain high in the next few years. In contrast, some traditional immunomodulators and biologics are more affordable in terms of price, but they have certain limitations in terms of onset of action, compliance, or side effects.

Reference materials:https://www.drugs.com/mtm/etrasimod.html